Due: April 15, 2026 The objective of this SSN / RFI is to better refine the requirements for host directed therapeutics for the prevention of progression to acute respiratory distress syndrome (ARDS) in support of Read More
Due: April 17, 2026 CPE CBRND is conducting essential market research for the Host-Directed Therapeutics (HD TX) program, a new initiative expected to launch in Fiscal Year 2027. This program is dedicated to identifying and Read More
Due: April 24, 2026 JPM CBRN Integrated Early Warning is developing AI/ML models to monitor physiological status, predict CBRN-related effects, and support Warfighter tactical decision making, readiness, and recovery. JPM CBRN Integrated Early Warning also Read More
Due: May 25, 2026 The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support HIV/AIDS Research Centers (ARC). The ARC is intended to provide Read More
Due: May 25, 2026 The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer, stem cell therapy trials, and other complex or high resource- or safety-risk clinical trials. These projects Read More
Due: May 14, 2026 The purpose of this document is to advise the public that NOAA/NOS/National Centers for Coastal Ocean Science (NCCOS) Competitive Research Program (NCCOS/CRP) [formerly Center for Sponsored Coastal Ocean Research (CSCOR)/Coastal Ocean Read More
Due: May 14, 2026 The purpose of this document is to advise the public that NOAA/NOS/National Centers for Coastal Ocean Science (NCCOS) Competitive Research Program (NCCOS/CRP) [formerly Center for Sponsored Coastal Ocean Research (CSCOR)/Coastal Ocean Read More
Due: May 7, 2026 The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through the development Read More
Due: May 7, 2026 This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted Read More
May 7, 2026 This Notice of Funding Funding Opportunity (NOFO) supports research on expectancy-generating factors and measures of their effects on expectancies and subsequent cancer symptom management outcomes; and research to identify moderators of such Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2026 - All rights reserved.